Ann: Trading Halt, page-80

We know the potential of this drug.

We know its multi acting, consistent (oh so consistent) and safe!

We add on DMOAD connotations, more to come tomorrow *fingers crossed*.

We know just how many inflammatory conditions there are and how many of those we may at least partially address in a good % of the population.

We, in my opinion must not sell this short...we want a Big Pharma partnership, NOT a buy out...a buyout at anything under x would be the saddest loss for us. A total wipe out of all that potential. I think there are enough smart and longer term holders that can stave this off but we would need every share we could muster. I want to see the day when x is much more than just $50 or $100 and we are reaping in half yearly dividends that are material.

I want to see the day when WE as owners also help society directly, the poorest and most suffering on a scale that matters while also being a compelling investment for us that have held for so long and so dearly.